Skip to content

Clinical trials

Phase 1 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 1 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20042
20053
20063
20079
20086
20092
20109
20113
20121
20132
20147
20152
20164
20173
20186
20192
20202
20214
20224
20234
20241
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Recruiting13
Unknown status8
Active, not recruiting5
Withdrawn5
Terminated4
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)9
GlaxoSmithKline5
Vitreous -Retina- Macula Consultants of New York3
Alcon Research2
Allergan2
Astellas Institute for Regenerative Medicine2
Chengdu Origen Biotechnology Co., Ltd.2
Exegenesis Bio2
Forsight Vision42
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration102
Choroidal Neovascularization16
Geographic Atrophy9
Eye Diseases8
Retinal Diseases8
Retinal Degeneration7
Diabetic Retinopathy6
Stargardt Disease6
Retinal Vein Occlusion5
Macular Edema4

Trials

Showing 76 to 100 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.